West Pharmaceutical Services, Inc. (WST)
353.31
+0.23
(+0.07%)
USD |
NYSE |
Aug 24, 16:00
353.31
0.00 (0.00%)
After-Hours: 20:00
West Pharmaceutical Services Enterprise Value : 24.74B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 24.74B |
| August 20, 2026 | 24.79B |
| August 19, 2026 | 24.72B |
| August 18, 2026 | 24.28B |
| August 17, 2026 | 24.28B |
| August 14, 2026 | 24.48B |
| August 13, 2026 | 24.25B |
| August 12, 2026 | 24.68B |
| August 11, 2026 | 24.62B |
| August 10, 2026 | 24.67B |
| August 07, 2026 | 24.81B |
| August 06, 2026 | 24.42B |
| August 05, 2026 | 24.59B |
| August 04, 2026 | 24.43B |
| August 03, 2026 | 24.38B |
| July 31, 2026 | 23.88B |
| July 30, 2026 | 23.79B |
| July 29, 2026 | 23.64B |
| July 28, 2026 | 23.61B |
| July 27, 2026 | 23.20B |
| July 24, 2026 | 22.99B |
| July 23, 2026 | 24.91B |
| July 22, 2026 | 25.11B |
| July 21, 2026 | 25.17B |
| July 20, 2026 | 24.68B |
| Date | Value |
|---|---|
| July 17, 2026 | 25.10B |
| July 16, 2026 | 25.40B |
| July 15, 2026 | 25.15B |
| July 14, 2026 | 25.06B |
| July 13, 2026 | 25.20B |
| July 10, 2026 | 24.78B |
| July 09, 2026 | 25.06B |
| July 08, 2026 | 24.78B |
| July 07, 2026 | 24.95B |
| July 06, 2026 | 25.06B |
| July 02, 2026 | 25.63B |
| July 01, 2026 | 25.58B |
| June 30, 2026 | 25.15B |
| June 29, 2026 | 24.95B |
| June 26, 2026 | 24.67B |
| June 25, 2026 | 24.37B |
| June 24, 2026 | 23.93B |
| June 23, 2026 | 23.65B |
| June 22, 2026 | 23.18B |
| June 18, 2026 | 23.05B |
| June 17, 2026 | 22.74B |
| June 16, 2026 | 23.17B |
| June 15, 2026 | 23.30B |
| June 12, 2026 | 23.11B |
| June 11, 2026 | 23.22B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 11.18B |
| Hinge Health, Inc. | 6.708B |
| Baxter International, Inc. | 20.30B |
| The Cooper Cos., Inc. | 17.18B |
| Becton, Dickinson & Co. | 68.24B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 154.00M |
| Revenue (Quarterly) | 872.40M |
| Total Expenses (Quarterly) | 718.40M |
| EPS Diluted (Quarterly) | 2.160 |
| Gross Profit Margin (Quarterly) | 37.83% |
| Profit Margin (Quarterly) | 17.65% |
| Earnings Yield | 2.21% |
| Operating Earnings Yield | 2.86% |
| Normalized Earnings Yield | 2.328 |